Literature DB >> 30657550

MiR-32-5p regulates the proliferation and metastasis of cervical cancer cells by targeting HOXB8.

Y-J Liu1, H-G Zhou, L-H Chen, D-C Qu, C-J Wang, Z-Y Xia, J-H Zheng.   

Abstract

OBJECTIVE: To investigate the effects of miR-32-5p on the biological behaviors of cervical cancer (CCa), the relevant mechanism was studied in CCa cell lines (HeLa) in vitro. PATIENTS AND METHODS: The expression level of miR-32-5p was detected by quantitative reverse transcription polymerase chain reaction (qRT-PCR). TargetScan, miRDB, microRNA databases and Luciferase method were conducted to predict and validate the target gene of miR-32-5p; the effects of miR-32-5p on cell proliferation, clone formation, invasion and migration capacity were analyzed in vitro study.
RESULTS: We found miR-32-5p to be significantly inhibited in CCa tissues and cells. Bioinformatics approach together with Luciferase method screened Homeobox B8 (HOXB8) as a downstream regulatory target of miR-32-5p. Besides, HOXB8 was incredibly high expression in CCa tissues and cells. After transfection in HeLa cells by miR-32-5p mimics, HOXB8 expression was indicated to be negatively correlated with miR-32-5p both in qRT-PCR and Western blot (WB) assays. The subsequent experiments showed that decreased expression of HOXB8 resulting from up-regulation of miR-32-5p could weaken the cell proliferation, clone formation, invasion and migration ability of HeLa cells.
CONCLUSIONS: MiR-32-5p could inhibit the cellular malignant behavior through regulating the expression of HOXB8 in HeLa cells. We provide a new clue for the study of molecular mechanisms of CCa. MiR-32-5p/HOXB8 axis might serve as potential target for the clinical diagnosis and treatment of CCa.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30657550     DOI: 10.26355/eurrev_201901_16752

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  15 in total

1.  SNHG14 promotes the tumorigenesis and metastasis of colorectal cancer through miR-32-5p/SKIL axis.

Authors:  Tao Ye; Ning Zhang; Wenyu Wu; Bing Yang; Jinghui Wang; Wenqi Huang; Dongxin Tang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2019-08-30       Impact factor: 2.416

2.  Analysis of the subcellular location of FAM230B and its interaction with premature miR-302b in osteosarcoma.

Authors:  Shigao Cheng; Wanchun Wang
Journal:  J Bone Miner Metab       Date:  2022-05-31       Impact factor: 2.626

Review 3.  The Role of NcRNAs to Regulate Immune Checkpoints in Cancer.

Authors:  Yicun Jiang; Leilei Zhao; Yiwen Wu; Sijun Deng; Pu Cao; Xiaoyong Lei; Xiaoyan Yang
Journal:  Front Immunol       Date:  2022-04-06       Impact factor: 8.786

4.  Integrated analysis of circular RNA-associated ceRNA network in cervical cancer: Observational Study.

Authors:  Jun Gong; Hui Jiang; Chang Shu; Mei-Qin Hu; Yan Huang; Qin Liu; Rong-Feng Li; Yin-Zhi Wei
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

5.  miR-27a-3p Functions as a Tumor Suppressor and Regulates Non-Small Cell Lung Cancer Cell Proliferation via Targeting HOXB8.

Authors:  Xiaohong Yan; Hui Yu; Yao Liu; Jie Hou; Qiao Yang; Yaning Zhao
Journal:  Technol Cancer Res Treat       Date:  2019-01-01

6.  MiR-32-5p aggravates intestinal epithelial cell injury in pediatric enteritis induced by Helicobacter pylori.

Authors:  Jing Feng; Jian Guo; Jun-Ping Wang; Bao-Feng Chai
Journal:  World J Gastroenterol       Date:  2019-11-07       Impact factor: 5.742

7.  Silence of miR-32-5p promotes endothelial cell viability by targeting KLF2 and serves as a diagnostic biomarker of acute myocardial infarction.

Authors:  Yunxiang Dai; Tingguo Yan; Yuming Gao
Journal:  Diagn Pathol       Date:  2020-03-03       Impact factor: 2.644

8.  MYC-activated lncRNA HNF1A-AS1 overexpression facilitates glioma progression via cooperating with miR-32-5p/SOX4 axis.

Authors:  Jianheng Wu; Rong Li; Linfan Li; Yimian Gu; Hui Zhan; Changbao Zhou; Chuanhong Zhong
Journal:  Cancer Med       Date:  2020-07-20       Impact factor: 4.452

9.  Long non‑coding RNA PITPNA‑AS1 silencing suppresses proliferation, metastasis and epithelial‑mesenchymal transition in non‑small cell lung cancer cells by targeting microRNA‑32‑5p.

Authors:  Gang Chen; Zhifeng Zheng; Junsheng Li; Peigang Zhang; Zhenjun Wang; Shiping Guo; Jun Ma; Jian Shen; Huixin Li
Journal:  Mol Med Rep       Date:  2021-01-26       Impact factor: 2.952

10.  lncRNA MT1JP-overexpression abolishes the silencing of PTEN by miR-32 in hepatocellular carcinoma.

Authors:  Shuhua Zhang; Jianqun Xu; Qing Chen; Fan Zhang; Hongjuan Wang; Hongrong Guo
Journal:  Oncol Lett       Date:  2021-06-15       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.